CorMedix Inc • CRMD

Capital at risk.

About CorMedix Inc
Ticker
info
CRMD
Trading on
info
NASDAQ
ISIN
info
US21900C3088
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Joseph Todisco MBA
Headquarters
info
300 Connell Drive, Berkeley Heights, NJ, United States, 07922
Employees
info
64
Website
info
cormedix.com
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
Metrics
BasicAdvanced
Market cap
info
$838M
P/E ratio
info
4.81
EPS
info
$2.21
Dividend Yield
info
0.00%
Beta
info
1.31
Forward P/E ratio
info
3.73
EBIDTA
info
$108M
Ex dividend date
info
-
Price & volume
Market cap
info
$838M
Average daily volume
info
3M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
4.81
Forward P/E
info
3.73
PEG ratio
info
0
Trailing P/E
info
4.81
Price to sales
info
3.91
Price to book
info
2.17
Earnings
EPS
info
$2.21
EPS estimate (current quarter)
info
$0.63
EPS estimate (next quarter)
info
$0.82
EBITDA
info
$108M
Revenues (TTM)
info
$214M
Revenues per share (TTM)
info
$3.17
Technicals
Beta
info
1.31
52-week High
info
$17.43
52-week Low
info
$5.60
50-day moving average
info
$10.84
200-day moving average
info
$11.14
Short ratio
info
5.82
Short %
info
22.36%
Management effectiveness
ROE (TTM)
info
75.08%
ROA (TTM)
info
15.69%
Profit margin
info
75.83%
Gross profit margin
info
$202M
Operating margin
info
49.24%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
810.20%
Share stats
Outstanding Shares
info
78.8M
Float
info
73.4M
Insiders %
info
7.09%
Institutions %
info
61.57%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 6 analysts.

Average price target

info
$19.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$0.22
$0.14
57.14%
Q4 • 24Beat
$0.30
$0.25
22.16%
Q1 • 25Beat
$0.28
$0.16
75.00%
Q2 • 25Beat
$1.41
$0.22
529.65%
Q3 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$39.7M
$19.8M
49.90%
Q2 • 25
$104M
$109M
104.11%
Q3 • 25
162.41%
447.52%
108.65%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$253M
$32M
12.66%
Q2 • 25
$751M
$377M
50.17%
Q3 • 25
197.25%
1,078.43%
296.44%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$30M
$-20.2M
$83.2M
$30M
Q2 • 25
$30.9M
$-291M
$151M
$30.4M
Q3 • 25
2.88%
1,341.34%
80.83%
1.28%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a CorMedix Inc share?
Collapse

CorMedix Inc shares are currently traded for undefined per share.

How many shares does CorMedix Inc have?
Collapse

CorMedix Inc currently has 78.8M shares.

Does CorMedix Inc pay dividends?
Collapse

No, CorMedix Inc doesn't pay dividends.

What is CorMedix Inc 52 week high?
Collapse

CorMedix Inc 52 week high is $17.43.

What is CorMedix Inc 52 week low?
Collapse

CorMedix Inc 52 week low is $5.60.

What is the 200-day moving average of CorMedix Inc?
Collapse

CorMedix Inc 200-day moving average is $11.14.

Who is CorMedix Inc CEO?
Collapse

The CEO of CorMedix Inc is Joseph Todisco MBA.

How many employees CorMedix Inc has?
Collapse

CorMedix Inc has 64 employees.

What is the market cap of CorMedix Inc?
Collapse

The market cap of CorMedix Inc is $838M.

What is the P/E of CorMedix Inc?
Collapse

The current P/E of CorMedix Inc is 4.81.

What is the EPS of CorMedix Inc?
Collapse

The EPS of CorMedix Inc is $2.21.

What is the PEG Ratio of CorMedix Inc?
Collapse

The PEG Ratio of CorMedix Inc is 0.

What do analysts say about CorMedix Inc?
Collapse

According to the analysts CorMedix Inc is considered a buy.